Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Kamon Shirakawa"'
Autor:
Gaku Takahashi, Kouichi Hoshikawa, Rioto Suzuki, Kotaro Sato, Shintaro Hoshi, Daisuke Yoshinao, Kamon Shirakawa
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-9 (2022)
Abstract Presepsin (sCD14-ST) is used as a marker for sepsis diagnosis. The production mechanism of presepsin is unique in that it is produced through phagocytosis of microorganisms. However, some studies have demonstrated that non-infected patients
Externí odkaz:
https://doaj.org/article/aed3ed7be4724b46865ea4d606594359
Publikováno v:
BioTechniques, Vol 70, Iss 3, Pp 160-166 (2021)
Presepsin is a 13-kDa N-terminal glycoprotein of CD14. Previously, agitation-induced increases in presepsin levels have been reported; however, the mechanism remains poorly understood. In this study, we aimed to reveal the mechanism of presepsin incr
Externí odkaz:
https://doaj.org/article/95dcf1ce3e88468692bb2bc6abb86422
Autor:
Kazuhiro Ando, Manabu Natsumeda, Masahide Kawamura, Kamon Shirakawa, Masayasu Okada, Yoshihiro Tsukamoto, Takeyoshi Eda, Jun Watanabe, Shoji Saito, Haruhiko Takahashi, Akiyoshi Kakita, Makoto Oishi, Yukihiko Fujii
Publikováno v:
Thrombosis Research. 223:36-43
Publikováno v:
BioTechniques. 70:160-166
Presepsin is a 13-kDa N-terminal glycoprotein of CD14. Previously, agitation-induced increases in presepsin levels have been reported; however, the mechanism remains poorly understood. In this study, we aimed to reveal the mechanism of presepsin incr
Publikováno v:
European journal of pharmacology. 806
Cluster of differentiation 14 (CD14), a pattern recognition receptor expressed on myeloid cells and a critical component of the innate immune system, mediates local and systemic host responses to gram-negative bacterial products, including lipopolysa
Autor:
Shoji Furusako, Kumiko Ogawa, Kamon Shirakawa, Motoyasu Honda, Katsuki Naitoh, Yoshitaka Hosaka
Publikováno v:
Platelets. 26(8)
Glycoprotein VI (GPVI) plays a critical role in the platelet response to collagen. Clinical studies suggest that the plasma level of soluble GPVI (sGPVI) is a highly specific and useful platelet activation marker. However, many properties of sGPVI ha
Autor:
Takashi Goto, Sumio Watanabe, Norio Nakamura, Masafumi Komatsu, Kazuo Yoneyama, Jiun Guey Lin, Kamon Shirakawa, Kunio Nakane, Kouichi Miura, Ken ichirou Mikami, Masashiro Sugawara, Shigetoshi Ohshima
Publikováno v:
Hepatology Research. 24:327-337
In viral hepatitis, binding of Fas ligand (FasL) with Fas expressed on the surfaces of infected hepatocytes induces apoptosis, removing hepatitis virus along with infected hepatocytes. We measured serum concentrations of soluble Fas (sFas) and FasL (
Publikováno v:
cclm. 49:937-939
Publikováno v:
Journal of immunological methods. 418
Soluble Glycoprotein VI (GPVI) is an attractive marker for disorders marked by platelet activation, such as thrombotic microangiopathy, myocardial infarction, and stroke. Several groups have already developed an immunoassay for soluble GPVI; however,
Autor:
Hidenori Mochizuki, Toshihiko Tsuda, Tomohiro Takahashi, Yoshitaka Hosaka, Shoji Furusako, Kamon Shirakawa, Kiyoshi Mizuguchi, Yutaka Kato
Publikováno v:
European Journal of Pharmacology. 428:371-379
The infiltration and activation of inflammatory cells play an important role in the formation and stability of coronary atherosclerotic plaque in patients with acute coronary syndrome. In this study, we evaluated the effect of trapidil, an anti-plate